We chose the human mutation p.Arg779His, as it has been reported that it is able to upregulate type I IFN in mice (18) and our main aim is to develop a zebrafish model of AGS to find new drugs that can abrogate IFN overexpression. The gene discussed is IFNA1; the disease is Aicardi-Goutieres syndrome.